✦ LIBER ✦

Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer

✍ Scribed by V. Guarneri; E. Barbieri; M.V. Dieci; F. Piacentini; P. Conte

Book ID: 117487896
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 100 KB
Volume: 36
Category: Article
ISSN: 0305-7372
DOI: 10.1016/s0305-7372(10)70022-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant Trastuzumab Therapy for HER2-Po

Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer

✍ Mohammad Jahanzeb 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 148 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

Adjuvant therapy of HER2+breast cancer

✍ EP Winer 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 461 KB

Adjuvant trastuzumab for HER2-positive b

Adjuvant trastuzumab for HER2-positive breast cancer

✍ James Spicer; Mark Harries; Paul Ellis 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 47 KB

Trastuzumab-based neoadjuvant therapy in

Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Neoadjuvant trastuzumab + FEC for HER2-p

Neoadjuvant trastuzumab + FEC for HER2-positive breast cancer

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB